Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

被引:11
作者
Choi, Seung Joon [1 ]
Kim, Jonghoon [2 ]
Seo, Jongbum [3 ]
Kim, Hyung Sik [1 ]
Lee, Jong-min [4 ]
Park, Hyunjin [2 ]
机构
[1] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea
[2] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea
[3] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea
[4] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea
来源
ABDOMINAL IMAGING | 2014年 / 39卷 / 03期
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; Parametric response mapping; Automatic classifier; Transcatheter arterial chemoembolization; Dynamic CT; Longitudinal exam; TRANSARTERIAL CHEMOEMBOLIZATION; LIPIODOL-CHEMOEMBOLIZATION; EMBOLIZATION; THERAPY; MAP; LIVER; RECURRENCES; COMBINATION; MANAGEMENT; SORAFENIB;
D O I
10.1007/s00261-014-0087-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches. Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87. We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
[31]   Reactivation of tuberculosis in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A report of 3 cases [J].
Kim, Yun Jeung ;
Goh, Pyung Gohn ;
Moon, Hee Seok ;
Lee, Eaum Seok ;
Kim, Seok Hyun ;
Lee, Byung Seok ;
Lee, Heon Young .
WORLD JOURNAL OF RADIOLOGY, 2012, 4 (05) :236-240
[32]   C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma [J].
Li, Jian-Jun ;
Zheng, Jia-Sheng ;
Cui, Shi-Chang ;
Cui, Xiong-Wei ;
Hu, Cai-Xia ;
Fang, Da ;
Ye, Lin-Chao .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (10) :3035-3040
[33]   The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma [J].
Du, Feizhou ;
Jiang, Rui ;
Gu, Ming ;
He, Ci ;
Guan, Jing .
RADIOLOGIA MEDICA, 2015, 120 (08) :690-694
[34]   The feasibility of early response evaluation using superb microvascular imaging one day after transcatheter arterial chemoembolization for hepatocellular carcinoma [J].
Oh, Soeui ;
Kwon, Heejin ;
Lim, Kyungjae ;
Cho, Jinhan ;
Kang, Eunju ;
Kim, Sanghyun ;
Baek, Yanghyun .
JOURNAL OF CLINICAL ULTRASOUND, 2023, 51 (05) :866-875
[35]   Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization [J].
Gu, Jiong-Hui ;
Zhao, Qi-Yu ;
He, Chang ;
Ye, Zheng-Du ;
Xu, Min ;
Jiang, Tian-An .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2021, 38 (01) :1092-1098
[36]   Added Value of CT Arterial Subtraction Images in Liver Imaging Reporting and Data System Treatment Response Categorization for Transcatheter Arterial Chemoembolization-Treated Hepatocellular Carcinoma [J].
Huh, Jimi ;
Kim, Bohyun ;
Lee, Jei Hee ;
Won, Je Hwan ;
Kim, Jinoo ;
Kwon, Yohan ;
Kim, Jai Keun .
INVESTIGATIVE RADIOLOGY, 2021, 56 (02) :109-116
[37]   Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE [J].
Jan B. Hinrichs ;
Hoen-Oh Shin ;
Daniel Kaercher ;
Davut Hasdemir ;
Tim Murray ;
Till Kaireit ;
Carolin Lutat ;
Arndt Vogel ;
Bernhard C. Meyer ;
Frank K. Wacker ;
Thomas Rodt .
European Radiology, 2016, 26 :3447-3455
[38]   Prognostic value of serum γ-glutamyl transferase in unresectable hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization combined with conformal radiotherapy [J].
Chen, Dung ;
Wang, Renben ;
Meng, Xiangjiao ;
Yan, Hongjiang ;
Jiang, Shumei ;
Feng, Rui ;
Zhu, Kunli ;
Xu, Xiaoqing ;
Dou, Xue ;
Jin, Linzhi .
ONCOLOGY LETTERS, 2014, 8 (05) :2298-2304
[39]   Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma [J].
Kim, Chang Joon ;
Kim, Hong Joo ;
Park, Jung Ho ;
Park, Dong Il ;
Cho, Yong Kyun ;
Sohn, Chong Il ;
Jeon, Woo Kyu ;
Kim, Byung Ik ;
Kim, Min-Ji .
LIVER INTERNATIONAL, 2014, 34 (02) :305-312
[40]   Intraprocedural Transcatheter Intra-arterial Perfusion MRI as a Predictor of Tumor Response to Chemoembolization for Hepatocellular Carcinoma [J].
Wang, Dingxin ;
Galin, Ron C. ;
Jin, Brian ;
Riaz, Ahsun ;
Lewandowski, Robert J. ;
Ryu, Robert K. ;
Sato, Kent T. ;
Ragin, Ann B. ;
Kulik, Laura M. ;
Mulcahy, Mary F. ;
Salem, Riad ;
Larson, Andrew C. ;
Omary, Reed A. .
ACADEMIC RADIOLOGY, 2011, 18 (07) :828-836